Topics

Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests

07:05 EDT 5 Sep 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
In the U.S., 25 million people suffer from asthma, the majority of which have allergic asthma. Allergic asthma can be life threatening. This makes access to prompt, accurate diagnosis and appropriate treatment vital. Abionic's 5-minute point-of-care ...

Other Sources for this Article

Abionic SA
Dr. Nicolas Durand, CEO
+41 (0)21 353 33 80
info@abionic.com
Abionic SA Address
Biopole SE-B, Corniche 5
CH-1066 Epalinges, Switzerland
www.abionic.com

NEXT ARTICLE

More From BioPortfolio on "Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests"

Quick Search

Relevant Topics

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...